The Quest for Clinical Innovation - Featured Reprint: PharmaVoice 100


Read and download the reprint from PharmaVoice, featuring Cenduit CEO Sam Osman among the 2019 PharmaVoice 100.

Excerpt: “With a quest to drive better connectivity among people, processes and technologies, Sam Osman has been redefining Cenduit’s focus from solely providing interactive response technology (IRT) to helping sponsors gain better control of their trials with complementary eClinical technologies and services…”

Access and download the PharmaVoice reprint: